Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Frates James M
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   318,827    

Indirect Shares

   184,010      
Direct Value   $2,148,775    

Indirect Value

   $3,642,655      
Total Shares   502,837      
Total Value   $5,791,430      


Alkermes Plc $2,148,775 Sage Therapeutics, Inc. $0 Amylyx Pharmaceuticals, Inc. $0 Alkermes Plc $2,148,775 Sage Therapeutics, Inc. $0 Amylyx Pharmaceuticals, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alkermes Plc ALKS SVP, Alks Inc; CFO ALKS 2020-05-14 91,828 2020-05-14 155,669    Premium*  
            Sage Therapeutics, Inc. SAGE 2021-06-16 1,035 2021-06-16 1,810    Premium*  
            Amylyx Pharmaceuticals, Inc. AMLX 2024-04-16 225,964 2024-04-16 26,531    Premium*  
* Premium Members only  

Records found :    262         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2023-03-16 4/A A $0.00 $0 D/D 21,667 55,676 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2023-10-31 4 GA $0.00 $0 I/I 11,072 11,072 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2024-02-26 4 A $0.00 $0 D/D 40,000 152,035 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2024-04-16 4 A $0.00 $0 D/D 91,180 225,964 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2011-12-01 4 OE $4.77 $23,850 D/D 5,000 83,871 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2011-12-27 4 OE $4.77 $35,794 D/D 7,504 79,625 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2012-02-21 4 OE $4.77 $23,850 D/D 5,000 84,625 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2012-06-13 4 OE $4.77 $11,729 D/D 2,459 88,551 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2012-06-20 4 OE $4.77 $11,729 D/D 2,459 88,551 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2012-06-27 4 OE $4.77 $11,729 D/D 2,459 88,551 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-07-03 4 OE $4.77 $11,729 D/D 2,459 88,551 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-07-11 4 OE $4.77 $11,734 D/D 2,460 88,552 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2022-12-30 4 OE $6.88 $34,400 D/D 5,000 36,667 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2023-03-16 4/A OE $6.88 $223,600 D/D 32,500 66,509 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2023-05-16 4 OE $6.88 $223,600 D/D 32,500 88,176 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Financial Officer   •       –      –    2023-08-23 4 OE $6.88 $124,975 D/D 18,165 106,341 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       –      –    2012-02-01 4 OE $7.36 $73,600 D/D 10,000 89,625 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-08-08 4 OE $7.36 $39,472 D/D 5,363 91,455 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-08-15 4 OE $7.36 $39,472 D/D 5,363 91,455 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-09-26 4 OE $7.36 $39,472 D/D 5,363 91,455 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-10-03 4 OE $7.36 $39,472 D/D 5,363 91,455 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-10-10 4 OE $7.36 $39,479 D/D 5,364 91,456 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-10-17 4 OE $7.36 $39,479 D/D 5,364 91,456 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-11-13 4 OE $7.36 $151,461 D/D 17,476 99,248 0 -
ALKS Alkermes Plc SVP & CFO, Alkermes plc   •       •      –    2012-11-14 4 OE $7.36 $39,479 D/D 5,364 101,432 0 -
  262  Records found
  1   2   3  4   5   6   7   8   9   10   11      
  Page 3 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us